 |
72 Diseases |  |
9 Trials |
|
9 Trials |  |
596 News |  |
| «12345678 |
- ||||||| rasagiline / Generic mfg.
Trial completion: Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China (clinicaltrials.gov) - Dec 26, 2013
P3, N=130, Completed, Sponsor: H. Lundbeck A/S
Recruiting --> Completed
- ||| rasagiline / Generic mfg.
Trial completion: A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline (clinicaltrials.gov) - Dec 18, 2013
P1, N=64, Completed, Sponsor: Teva Pharmaceutical Industries
Recruiting --> Completed Active, not recruiting --> Completed
- rasagiline / Generic mfg.
Enrollment open: Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS) (clinicaltrials.gov) - Nov 26, 2013
P2, N=80, Recruiting, Sponsor: Richard Barohn, MD
Active, not recruiting --> Completed Active, not recruiting --> Recruiting
- | rasagiline / Generic mfg.
Enrollment closed: PD-SOAR: A Study Assessing Change in Sense of Smell After Rasagiline Use in Parkinson's Patients (clinicaltrials.gov) - Nov 26, 2013
P4, N=36, Active, not recruiting, Sponsor: The Parkinson's Institute
Active, not recruiting --> Recruiting Recruiting --> Active, not recruiting
- ||||||| rasagiline / Generic mfg.
Trial completion: CHORAL: Azilect (clinicaltrials.gov) - Sep 10, 2013
P3, N=321, Completed, Sponsor: H. Lundbeck A/S
Recruiting --> Active, not recruiting Recruiting --> Completed
- | preladenant (SCH 420814) / Merck (MSD)
Trial termination: An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153) (clinicaltrials.gov) - Jul 18, 2013
P3, N=841, Terminated, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Completed Active, not recruiting --> Terminated
- | preladenant (SCH 420814) / Merck (MSD)
Trial termination: PARADYSE: A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (PD) (P05664) (clinicaltrials.gov) - Jul 18, 2013
P3, N=1022, Terminated, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Terminated Active, not recruiting --> Terminated; Termininated for business reasons
- ||||||| rasagiline / Generic mfg.
Trial completion: Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations (clinicaltrials.gov) - Jul 3, 2013
P3, N=268, Completed, Sponsor: Chongqing Fortune Pharmaceutical Co., Ltd.
Active, not recruiting --> Terminated; Termininated for business reasons Recruiting --> Completed
- |||| rasagiline / Generic mfg.
Trial completion: ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects (clinicaltrials.gov) - Jun 27, 2013
P4, N=684, Completed, Sponsor: Teva Pharmaceutical Industries
Recruiting --> Completed Active, not recruiting --> Completed
- rasagiline / Generic mfg.
Enrollment change: Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia (clinicaltrials.gov) - Jun 16, 2013
P4, N=84, Completed, Sponsor: University of Maryland
Active, not recruiting --> Completed N=60 --> 84
- ||| rasagiline / Generic mfg.
New P1 trial: A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline (clinicaltrials.gov) - Jun 16, 2013
P1, N=64, Completed, Sponsor: Teva Pharmaceutical Industries
- rasagiline / Generic mfg.
Trial completion: Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia (clinicaltrials.gov) - Jun 16, 2013
P4, N=84, Completed, Sponsor: University of Maryland
N=60 --> 84 Recruiting --> Completed
- | riluzole / Generic mfg., rasagiline / Generic mfg.
New P2 trial: Study of Rasagiline in Patients With Amyotrophic Lateral Sclerosis (clinicaltrials.gov) - Jun 13, 2013
P2, N=250, Recruiting, Sponsor: University of Ulm
- | rasagiline / Generic mfg.
Trial termination: RAS-RLS: Safety and Efficacy of Rasagiline in Restless Legs Syndrome (clinicaltrials.gov) - Feb 7, 2013
P2/3, N=52, Terminated, Sponsor: University of Virginia
Recruiting --> Completed Recruiting --> Terminated; Slow enrollment
- | rasagiline / Generic mfg.
New P2 trial: Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS) (clinicaltrials.gov) - Feb 6, 2013
P2, N=80, Recruiting, Sponsor: Richard Barohn, MD
- |||| rasagiline / Generic mfg.
Trial completion: ANDANTE: Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease (clinicaltrials.gov) - Jan 27, 2013
P4, N=239, Completed, Sponsor: Teva Neuroscience, Inc.
Recruiting --> Terminated; Slow enrollment Active, not recruiting --> Completed
- ||||||| preladenant (SCH 420814) / Merck (MSD)
Trial completion: A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (P04938) (clinicaltrials.gov) - Jan 22, 2013
P3, N=778, Completed, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- rasagiline / Generic mfg.
New P4 trial: Evaluation of the Efficacy of Rasagiline in Apathy in Drug-na (clinicaltrials.gov) - Jan 8, 2013
P4, N=50, Not yet recruiting, Sponsor: University Hospital, Clermont-Ferrand
- |||||||||| rasagiline / Generic mfg.
New P3 trial: Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations (clinicaltrials.gov) - Nov 27, 2012
P3, N=268, Completed, Sponsor: Chongqing Fortune Pharmaceutical Co., Ltd.
- rasagiline / Generic mfg.
Trial termination: PROSPERA: Efficacy, Tolerability and Safety of Azilect in Subjects With Progressive Supranuclear Palsy (clinicaltrials.gov) - Nov 6, 2012
P3, N=44, Terminated, Sponsor: Prof. Dr. Stefan Lorenzl
with PSP. Thus no more eligible patients were available for the study(pre-treatm.with Rasagiline=exclusion criterion
- rasagiline / Generic mfg.
Enrollment change: PROSPERA: Efficacy, Tolerability and Safety of Azilect in Subjects With Progressive Supranuclear Palsy (clinicaltrials.gov) - Nov 6, 2012
P3, N=44, Terminated, Sponsor: Prof. Dr. Stefan Lorenzl
Thus no more eligible patients were available for the study(pre-treatm.with Rasagiline=exclusion criterion N=112 --> 44
- ||||| rasagiline / Generic mfg.
New P4 trial: Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease (clinicaltrials.gov) - Nov 5, 2012
P4, N=170, Recruiting, Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
- rasagiline / Generic mfg.
Trial termination: Ras-PDS-1: Multicenter Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's Disease (clinicaltrials.gov) - Oct 2, 2012
P4, N=1, Terminated, Sponsor: University of Zurich
N=112 --> 44 Recruiting --> Terminated; payments stopped by grant provider
- rasagiline / Generic mfg.
Enrollment change: Ras-PDS-1: Multicenter Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's Disease (clinicaltrials.gov) - Oct 2, 2012
P4, N=1, Terminated, Sponsor: University of Zurich
Recruiting --> Terminated; payments stopped by grant provider N=60 --> 1
- rasagiline / Generic mfg.
Trial completion: REST: Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease (clinicaltrials.gov) - Sep 16, 2012
P4, N=30, Completed, Sponsor: University of Florida
N=60 --> 1 Recruiting --> Completed
- | rasagiline / Generic mfg.
New P1 trial: Pharmacokinetic Properties of Rasagiline (Lu 00-773) in Healthy Young Chinese Men and Women (clinicaltrials.gov) - Jul 26, 2012
P1, N=12, Completed, Sponsor: H. Lundbeck A/S
- |||| rasagiline / Generic mfg.
Trial completion: ACCORDO: Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn (clinicaltrials.gov) - Jul 1, 2012
P4, N=121, Completed, Sponsor: Lundbeck Italia S.p.A.
Recruiting --> Completed Recruiting --> Completed
- ||||||| rasagiline / Generic mfg.
Trial completion: Study of Azilect (clinicaltrials.gov) - Jun 28, 2012
P3, N=132, Completed, Sponsor: H. Lundbeck A/S
Recruiting --> Completed Active, not recruiting --> Completed
- rasagiline / Generic mfg.
Trial initiation date: Trial of Safety and Efficacy of Rasagiline in Patients With Amyotrophic Lateral Sclerosis (ALS) (clinicaltrials.gov) - Mar 28, 2012
P2, N=30, Active, not recruiting, Sponsor: Yunxia Wang, MD
Active, not recruiting --> Completed Initiation date: Sep 2010 --> Dec 2011
- rasagiline / Generic mfg.
Enrollment change: Trial of Safety and Efficacy of Rasagiline in Patients With Amyotrophic Lateral Sclerosis (ALS) (clinicaltrials.gov) - Mar 28, 2012
P2, N=30, Active, not recruiting, Sponsor: Yunxia Wang, MD
Initiation date: Sep 2010 --> Dec 2011 N=60 --> 30
- rasagiline / Generic mfg.
Enrollment closed: Trial of Safety and Efficacy of Rasagiline in Patients With Amyotrophic Lateral Sclerosis (ALS) (clinicaltrials.gov) - Mar 28, 2012
P2, N=30, Active, not recruiting, Sponsor: Yunxia Wang, MD
N=60 --> 30 Recruiting --> Active, not recruiting
- |||||||||| rasagiline / Generic mfg.
New P3 trial: Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China (clinicaltrials.gov) - Mar 14, 2012
P3, N=130, Completed, Sponsor: H. Lundbeck A/S
- rasagiline / Generic mfg.
Enrollment change: Olfaction in Patients With Parkinson's Disease Following Treatment With Rasagiline (clinicaltrials.gov) - Feb 5, 2012
P4, N=34, Completed, Sponsor: Technische Universit
Recruiting --> Active, not recruiting N=60 --> 34
- |||| rasagiline / Generic mfg.
Trial completion: Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P) (clinicaltrials.gov) - Feb 5, 2012
P2, N=174, Completed, Sponsor: Teva Pharmaceutical Industries
N=60 --> 34 Active, not recruiting --> Completed
- rasagiline / Generic mfg.
Trial completion: Olfaction in Patients With Parkinson's Disease Following Treatment With Rasagiline (clinicaltrials.gov) - Feb 5, 2012
P4, N=34, Completed, Sponsor: Technische Universit
Active, not recruiting --> Completed Recruiting --> Completed
- | Ongentys (opicapone) / Ono Pharma, Neurocrine, BIAL
New P1 trial: Effect of Rasagiline on BIA 9-1067 Pharmacokinetics (clinicaltrials.gov) - Jan 22, 2012
P1, N=24, Completed, Sponsor: Bial - Portela C S.A.
- | Ongentys (opicapone) / Ono Pharma, Neurocrine, BIAL
New P1 trial: Effect of BIA 9-1067 on Rasagiline Pharmacokinetics (clinicaltrials.gov) - Jan 22, 2012
P1, N=24, Completed, Sponsor: Bial - Portela C S.A.
- ||| rasagiline / Generic mfg.
Enrollment change: Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P) (clinicaltrials.gov) - Jan 18, 2012
P2, N=174, Completed, Sponsor: Teva Pharmaceutical Industries
Recruiting --> Completed N=140 --> 174
- ||| rasagiline / Generic mfg.
Enrollment change: ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects (clinicaltrials.gov) - Jan 17, 2012
P4, N=684, Completed, Sponsor: Teva Pharmaceutical Industries
N=140 --> 174 N=1000 --> 684
- | rasagiline / Generic mfg.
New P4 trial: A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy (clinicaltrials.gov) - Dec 19, 2011
P4, N=40, Enrolling by invitation, Sponsor: Georgetown University
- |||||||||| rasagiline / Generic mfg.
New P3 trial: CHORAL: Azilect (clinicaltrials.gov) - Nov 22, 2011
P3, N=321, Completed, Sponsor: H. Lundbeck A/S
- | rasagiline / Generic mfg.
New P4 trial: RaSPar: Effects of Rasagiline on Sleep Disturbances in Parkinson's Disease (clinicaltrials.gov) - Sep 22, 2011
P4, N=30, Not yet recruiting, Sponsor: Dresden University of Technology